(2R,3S,4R,5R,6S)-2-(Hydroxymethyl)-6-(3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol
(2R,3S,4R,5R,6S)-2-(Hydroxymethyl)-6-(3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol is an impurity of Empagliflozin which is utilised along with diet and exercise, and sometimes with other medications, to lower blood sugar levels in people with type 2 diabetes. It is also utilised to reduce the risk of stroke, heart attack, or death in people who have type 2 diabetes along with heart and blood vessel disease.
Additional information on (2R | 3S | 4R | 5R | 6S)-2-(Hydroxymethyl)-6-(3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3 | 4 | 5-triol
Catalogue No.
VE008784
CAS No.
N/A
Molecular Formula
C23H28O7
Molecular Weight
416.46 g/mol
Parent drug
Empagliflozin
IUPAC Name
(2R, 3S, 4R, 5R, 6S)-2-(Hydroxymethyl)-6-(3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3, 4, 5-triol
Synonyms
N/A
References
“Empagliflozin: MedlinePlus Drug Information.” Medlineplus.gov, 2021, medlineplus.gov/druginfo/meds/a614043.html.
Status
In-stock
